Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2014-04-30
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Presence of Microbes in the Sperm and Their Impact on Sperm Capacitation and IVF Treatment
NCT02585297
Evaluation of Discarded Laboratory Pathological Specimens and Media
NCT01219439
The Effect of Covid-19 Vaccination in Patients Undergoing IVF
NCT05063942
Prospective Observational Correlation of Sperm Assay Results With Blastocyst Formation
NCT02031549
Evaluation of the Impact of Stress on IVF Outcome
NCT05589571
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
women with metabolic syndrome
women undergoing ivf treatment who have BMI\>25 and meet the criteria for metabolic syndrome
No interventions assigned to this group
women without metabolic syndrome
women undergoing ivf treatment who have BMI\>25 and who do not meet the criteria for metabolic syndrome
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* acute conditions
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Meir Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amir Waiser, M.D
Role: PRINCIPAL_INVESTIGATOR
"Meir", Medical centere
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sapir Medical Center, Meir Hospital
Kfar Saba, Israel, Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MMC-16092013-CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.